Caroline Diaz
Conseiller Juridique Général chez DOVA PHARMACEUTICALS, INC.
Postes actifs de Caroline Diaz
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DOVA PHARMACEUTICALS, INC. | Conseiller Juridique Général | - | - |
| VERONA PHARMA PLC | Conseiller Juridique Général | 01/10/2021 | - |
Historique de carrière de Caroline Diaz
Anciens postes connus de Caroline Diaz
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Conseiller Juridique Général | - | - |
Formation de Caroline Diaz
| Hope College | Undergraduate Degree |
| University of North Carolina at Chapel Hill | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Royaume-Uni | 3 |
Opérationnelle
| General Counsel | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VERONA PHARMA PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Caroline Diaz
- Expérience
